SOURCE: Varian Semiconductor

May 29, 2007 13:30 ET

Varian Semiconductor Ranks Among the Top on The Boston Globe 100 List

This Marks the Fifth Consecutive Year That Varian Semiconductor Has Been Listed Among the Top Ranked Massachusetts-Based Public Companies

GLOUCESTER, MA--(Marketwire - May 29, 2007) - Varian Semiconductor Equipment Associates, Inc. (NASDAQ: VSEA) has been named to the "Globe 100" list of top performing public companies in Massachusetts, The Boston Globe announced today. This marks the fifth consecutive year that Varian Semiconductor has been ranked in the "Globe 100" list.

Based on a composite score derived from financial data for the four quarters ending December 31, 2006, Varian Semiconductor was ranked 13th among Massachusetts-based companies whose stock is publicly traded on NASDAQ, the New York Stock Exchange or the American Stock Exchange. Last year, Varian Semiconductor ranked 70th on this list.

"The companies in the Globe 100 have distinguished themselves in not only their respective fields, but among other Massachusetts businesses," said Globe Business Editor Shirley Leung.

To qualify for the Globe 100, a company must have been public for the entire 2006 calendar year and have reported a positive net income for both 2005 and 2006.

"We are honored that The Boston Globe has once again recognized Varian Semiconductor for its outstanding performance," said Gary Dickerson, Chief Executive Officer of Varian Semiconductor. "Achieving this recognition and this significant improvement in ranking from year to year is possible because of the quality of our industry-leading products and services, the loyalty of our customers, and, above all, the commitment and dedication of our employees worldwide."

About Varian Semiconductor

Varian Semiconductor Equipment Associates is the leading supplier of ion implant equipment to semiconductor manufacturers, enabling them to pack more, higher performing transistors into computer chips that are revolutionizing the electronics industry. Varian Semiconductor's products are used by chip manufacturers worldwide to produce high-performance semiconductor devices. Customers have made Varian Semiconductor the market leader in ion implant because of its architecturally superior products that lower their costs and improve their productivity. The Company has ranked #1 in the VLSI Research Customer Satisfaction Survey nine times over the last 10 years. Varian Semiconductor operates globally and is headquartered in Gloucester, Massachusetts. More information can be found on Varian Semiconductor's web site at www.vsea.com.

About The Boston Globe

The Boston Globe is wholly owned by The New York Times (NYSE: NYT), a leading media company with 2006 revenues of $3.3 billion, including The New York Times, the International Herald Tribune, The Boston Globe, 15 other daily newspapers, WQXR-FM and more than 30 web sites, including NYTimes.com, Boston.com and About.com. The Company's core purpose is to enhance society by creating, collecting and distributing high quality news, information and entertainment.

Note: This release contains forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. For this purpose, the statements concerning the Company's performance, market share and technology leadership, technological capabilities and benefits and growth are forward-looking statements and any statements using the terms "believes," "anticipates," "expects," "plans," or similar expressions are forward-looking statements. There are a number of important risks and factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These include, among others, volatility in the semiconductor equipment industry; economic conditions in general and as they affect the Company's customers; significant fluctuations in the Company's quarterly operating results; the impact of rapid technological change; the Company's dependence on the development and introduction of new products; the Company's concentration on ion implantation systems and related products; concentration in the Company's customer base and lengthy sales cycles; the highly competitive market in which the Company competes; the risks associated with international sales; foreign currency risks; and general economic conditions; and other factors identified in the Company's Annual Report on Form 10-K, and the most recent Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission. The Company cannot guarantee any future results, levels of activity, performance or achievement. The Company undertakes no obligation to update any of the forward-looking statements after the date of this press release.

Contact Information

  • Contacts:
    Bob Halliday
    Executive Vice President
    Chief Financial Officer
    978.282.7597
    or
    Mary Wright
    Director, Investor Relations
    978.282.5859